Back

Unravelling undiagnosed rare disease cases by HiFi long-read genome sequencing

Steyaert, W.; Sagath, L.; Demidov, G.; Yepez, V. A.; Esteve-Codina, A.; Gagneur, J.; Ellwanger, K.; Derks, R.; Weiss, M.; den Ouden, A.; van den Heuvel, S.; Swinkels, H.; Zomer, N.; Steehouwer, M.; O'Gorman, L.; Astuti, G.; Neveling, K.; Schule, R.; Xu, J.; Synofzik, M.; Beijer, D.; Hengel, H.; Schoels, L.; Claeys, K. G.; Baets, J.; Van de Vondel, L.; Ferlini, A.; Selvatici, R.; Morsy, H.; Saeed Abd Elmaksoud, M.; Straub, V.; Muller, J.; Pini, V.; Perry, L.; Sarkozy, A.; Zaharieva, I.; Muntoni, F.; Bugiardini, E.; Polavarapu, K.; Horvath, R.; Reid, E.; Lochmuller, H.; Spinazzi, M.; Savarese, M

2024-05-04 genetic and genomic medicine
10.1101/2024.05.03.24305331 medRxiv
Show abstract

Solve-RD is a pan-European rare disease (RD) research program that aims to identify disease-causing genetic variants in previously undiagnosed RD families. We utilised 10-fold coverage HiFi long-read sequencing (LRS) for detecting causative structural variants (SVs), single nucleotide variants (SNVs), insertion-deletions (InDels), and short tandem repeat (STR) expansions in extensively studied RD families without clear molecular diagnoses. Our cohort includes 293 individuals from 114 genetically undiagnosed RD families selected by European Rare Disease Network (ERN) experts. Of these, 21 families were affected by so-called unsolvable syndromes for which genetic causes remain unknown, and 93 families with at least one individual affected by a rare neurological, neuromuscular, or epilepsy disorder without genetic diagnosis despite extensive prior testing. Clinical interpretation and orthogonal validation of variants in known disease genes yielded thirteen novel genetic diagnoses due to de novo and rare inherited SNVs, InDels, SVs, and STR expansions. In an additional four families, we identified a candidate disease-causing SV affecting several genes including an MCF2/FGF13 fusion and PSMA3 deletion. However, no common genetic cause was identified in any of the unsolvable syndromes. Taken together, we found (likely) disease-causing genetic variants in 13.0% of previously unsolved families and additional candidate disease-causing SVs in another 4.3% of these families. In conclusion, our results demonstrate the added value of HiFi long-read genome sequencing in undiagnosed rare diseases.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.